Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial

SIMPLE SUMMARY: The availability of a child-friendly drug formulation can be an important determinant of therapeutic success. 13-cis-retinoic acid (13-CRA) is a key component of high-risk neuroblastoma treatment protocols, and yet there is no such formulation available in any country worldwide. Typi...

Descripción completa

Detalles Bibliográficos
Autores principales: Veal, Gareth J., Tweddle, Deborah A., Visser, Johannes, Errington, Julie, Buck, Helen, Marange, Josephine, Moss, Jon, Joseph, Shiju, Mulla, Hussain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070696/
https://www.ncbi.nlm.nih.gov/pubmed/33919763
http://dx.doi.org/10.3390/cancers13081868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070696/
https://www.ncbi.nlm.nih.gov/pubmed/33919763
http://dx.doi.org/10.3390/cancers13081868

Ejemplares similares